(AMN).Other neurological disorders    that may be served by RPI-78M include Myasthenia Gravis (MG) and
Amyotrophic Lateral Sclerosis (ALS) * Collaboration: University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple
2) NYLOXIN Non addictive pain solutions - OPIOID Alternative (FDA Registered) * Amazon today * Soon to be in retail   https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474 * Ongoing efforts to get our products into the VA and government buyers(Rik)-Article below shows VA need today!   https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474    Opioid abuse crisis takes heavy toll on US Veterans ...    November 10, 2017    President Donald Trump named opioids a national public health emergency and a White House commission last
week recommended    establishing a nationwide system of drug courts and easier access to
non-narcotic. In the last model, it outperformed morphine. It lasted six hours longer than morphine without any of
the side effects,” explained Rik Deitsch, CEO of Nutra Pharma Corp. https://www.nbcmiami.com/news/local/South-Florida-Company-Turns-Cobra-Venom-Into-Healing-Treatment-413791863.html * Supported by Jack Brewer. Non addictive pain solutions!!!! Retweeted!!!!  Jack Brewer @JackBrewerBSI Oct 2  I don’t know what I would do without my @nyloxin!! Keeps me going  Jack Brewer is the Executive Chairman & Portfolio Manager of The Brewer Group.  Very successful investor/financier and has connections with Bio Tech!!! Visits Fox Business frequently!
4) Pink Sheet "CURRENT" (Audited). * U.S. Reporting: SEC Reporting "Current" - Folks we are NOT some deregistered non-audited holding. We are fully SEC reporting. * Audited means everything to me, many pinkies aren't. * SOS Active and Current * Recently a "QB" stock dropped to pinky some months ago when we dipped below a penny. * When we bust into pennies again we will get back to "QB" quickly. http://www.otcmarkets.com/stock/NPHC/profile
10) Undervalued (NOT FOR LONG) because of toxic's that are close to being if not already completed!
11) Vastly Undervalued compared to other Bio's and Pharma with less in their pipelines.
12) No planned R/S in near future.
13) Email from Rik (Great things on the horizon) CEO UPDATE: NPHC We need to file our 10Q next week. After that, we can announce our ‘go-forward’ plans for the company. This includes: the ongoing
infomercial campaign for Pet Pain-Away; the marketing of Nyloxin; the retail rollout for Nyloxin; the ongoing efforts
to get our products into the VA and government buyers; our efforts in International registrations for our products; and
our efforts in moving RPI-78M into clinical trials for Pediatric Multiple Sclerosis under our Orphan Designation. We are working
with finance partners and potential joint venture partners to bring in from $2M to $20M in furtherance of the business plan. We
expect to make announcements later this month to update our shareholders.
* What I noticed about this email. No reference of toxic's still in play. Normally correspondence with Rik would reflect the toxic's still being an issue. We will see.
REVIEW:
What irons are in the fire we do not know about? The items we have so far can be verified by 10Q's, websites, snapshots of
emails, etc. I am sure I have missed something. There are so many opportunities here. A few have brought up the issue of debt.
Folks this is OTC/pinky land. What stock doesn't have debt. Rik has already mentioned joint ventures. I believe Rik and others are
working out financing agreements with legitimate lenders which will enable NPHC to bring to market new and existing groundbreaking
and much needed solutions! The positives far out way the negatives and WE ARE AT THE GROUND FLOOR! Trips are
about as low as you can get folks! Just how many sub penny stocks have a portfolio of products and potential that NPHC currently
has? Then look at our current Market Cap. Enough said IMHO! There are never any guarantees in the land of pinky's but I like our
chances. The list above is filled with a multitude of material events all capable of driving up the Market Cap/PPS in quick
fashion. Like I have said before perform your own DD and see what you find.